SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013063
Filing Date
2022-08-10
Accepted
2022-08-10 16:09:01
Documents
67
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q imrx-20220630x10q.htm   iXBRL 10-Q 2661696
2 EX-31.1 imrx-20220630xex31d1.htm EX-31.1 14686
3 EX-31.2 imrx-20220630xex31d2.htm EX-31.2 15730
4 EX-32.1 imrx-20220630xex32d1.htm EX-32.1 9354
5 EX-32.2 imrx-20220630xex32d2.htm EX-32.2 9906
  Complete submission text file 0001558370-22-013063.txt   8252667

Data Files

Seq Description Document Type Size
6 EX-101.SCH imrx-20220630.xsd EX-101.SCH 41926
7 EX-101.CAL imrx-20220630_cal.xml EX-101.CAL 64741
8 EX-101.DEF imrx-20220630_def.xml EX-101.DEF 211840
9 EX-101.LAB imrx-20220630_lab.xml EX-101.LAB 418253
10 EX-101.PRE imrx-20220630_pre.xml EX-101.PRE 340199
61 EXTRACTED XBRL INSTANCE DOCUMENT imrx-20220630x10q_htm.xml XML 1342656
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40675 | Film No.: 221151893
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences